|
|
Post by stella on Nov 11, 2024 11:21:25 GMT -5
All of this hand-wringing and buyer's remorse. Yet, after 9-10 years you're still here? This investment has been a home-run. My average cost is $1.60. Maybe you should be questioning your investment abilities, not management's shortcomings? A home run is like Tesla or Nvidia. We are still farrrr below where we were since Afrezza approval where a lot of people bought in. Just because you timed it right during the extreme low periods does not make this a home run investment. Most stocks are up many multiples since their covid lows. "Just because you timed it right during the extreme low periods does not make this a home run investment."
Uh, yes it does. Let me clarify since you clearly didn't understand my post. It's been a homerun....in my opinion, for me. 4.5x bagger right now. Many many shares. It could be a 20x bagger. Instead of complaining about MNKD's past performance, in hindsight, maybe you and others should have invested in Tesla or Nvidia (to your point) if that's what you're comparing this investment to. What do the exasperated. mocking, critical posts about management accomplish? Quarter after quarter, the same complaints. If you don't like management and the direction of the company, then sell and move on. Sunk costs.
|
|
|
|
Post by jkendra on Nov 11, 2024 11:33:23 GMT -5
All of this hand-wringing and buyer's remorse. Yet, after 9-10 years you're still here? This investment has been a home-run. My average cost is $1.60. Maybe you should be questioning your investment abilities, not management's shortcomings? A home run is like Tesla or Nvidia. We are still farrrr below where we were since Afrezza approval where a lot of people bought in. Just because you timed it right during the extreme low periods does not make this a home run investment. Most stocks are up many multiples since their covid lows. Timed it right ? What were those people doing for the last 8 full years besides whining on the internet. |
|
|
|
Post by BD on Nov 11, 2024 15:04:17 GMT -5
My early investment in mnkd has definitely made me question my investment ability. You and me both. |
|
|
|
MNKD - 201
Nov 11, 2024 16:44:39 GMT -5
via mobile
Post by bones1026 on Nov 11, 2024 16:44:39 GMT -5
My early investment in mnkd has definitely made me question my investment ability. You and me both. Well now that’s its 7x higher than it was when all of you were complaining when we were at $1 about how badly our management team is , why not “cut your losses” and go find that “homerun” you’ve been looking for? |
|
|
|
Post by BD on Nov 11, 2024 17:50:23 GMT -5
bones, that's rude. You want to find where I've complained about management, aside from pointing out they've dumped shares? And since I lost everything I had in it, there weren't any losses to "cut". But I did go find my home run thank you very much, and therefore I can be in this now at a level that won't bring me to the edge of BK if I lose it all. No more options...
|
|
|
|
Post by ptass on Nov 11, 2024 17:58:32 GMT -5
I think people are happy but not over the moon because the stock price only fell so low due to the dilution that encouraged relentless shorting and was primarily caused by Mike's decision to fund a sales force. Keeping Afrezza in house had the benefit of showing the technology works but the cost was steep. Who knows where we'd be if a different path was chosen. I'm very happy with where the company is and where it's going but for the next year the stock price will probably not rise much. A lot of things should come to fruition in 2026. Thinking about selling everything and waiting until next fall to buy back in but I've held it so long it's hard for me to actually follow through.
|
|
|
|
Post by prcgorman2 on Nov 11, 2024 19:42:03 GMT -5
Not sure what timeframe you’re referring to, but the decision to fund a salesforce and market Afrezza pre-dates Mike’s tenure. And the choice to create a salesforce was somewhat forced on MannKind. The multi-billionaire namesake Dr. Al Mann passed away at the age of 92 and the Mann Group had fiduciary responsibilities that did not include continuing funding MannKind no matter what. There weren’t any buyers for MannKind or Afrezza so it was sink or swim and they decided to swim.
Mike was hired to create the marketing organization and to re-launch Afrezza instead of continuing to use the marketing created by Sanofi. He said from the outset that re-launch of a drug has less than 50/50 chance of being successful. I think he said 35% chance.
Mike’s (and Steven Binder’s) efforts were successful enough to keep the lights on until the treprostinil Phase 1 trials proved a viable pipeline candidate known as Tre-T for Treprostinil on TechnoSphere that is now known as Tyvaso DPI thanks to a partnership with United Therapeutics. That’s basically where we are now and Tyvaso DPI has been very successful and indications are it will continue to be a good source of royalties revenue that’s able to fund the Afrezza, clofazimine, and nintedanib trials.
Nintedanib Phase 1 went very well, so its another pipeline candidate which may attract another partnership. We should know by the end of 2025 how development and launch will be handled in-house or via a partnership presumably in 2026 once the nintedanib compound patent expires and assuming FDA approval.
|
|
|
|
MNKD - 201
Nov 11, 2024 20:24:03 GMT -5
via mobile
Post by ptass on Nov 11, 2024 20:24:03 GMT -5
Not sure you can definitively say there were no buyers. Did they even market it? Who knows.
|
|
|
|
Post by mpg54 on Nov 11, 2024 22:29:11 GMT -5
Not sure you can definitively say there were no buyers. Did they even market it? Who knows. Who was going to buy a drug that didn’t even have 10 million in sales at the time and a complex manufacturing process? The investment in Afrezza development was massive, selling for pennies made no sense either. If someone wanted it there would have been an offer, I can pretty much guarantee it would a be a very lowball offer. It’s been a painful ride but I’m glad it still here and I believe the potential remains. |
|
|
|
Post by longliner on Nov 11, 2024 22:42:09 GMT -5
bones, that's rude. You want to find where I've complained about management, aside from pointing out they've dumped shares? And since I lost everything I had in it, there weren't any losses to "cut". But I did go find my home run thank you very much, and therefore I can be in this now at a level that won't bring me to the edge of BK if I lose it all. No more options... Awe sweetie, rude is trying to steal our IP through HFM. You remember, something you had never heard of as you posted on another forum. What you have lost? What you have gained? Cresomo is still waiting for the buyout below 7, I'm not sure what you are waiting for? Buh bye. |
|
|
|
Post by BD on Nov 11, 2024 22:51:29 GMT -5
Deja vu... if you think I want your stinkin' IP you're very confused.
|
|
|
|
Post by longliner on Nov 11, 2024 22:52:08 GMT -5
Deja vu... if you think I want your stinkin' IP you're very confused.  As discussed before, you and I have very different incentives. I own shares. |
|
|
|
Post by prcgorman2 on Nov 11, 2024 23:43:16 GMT -5
Focus folks. MNKD is up big this year and so far seems to have legs. MNKD-201 may be a significant piece of that with investors taking advice from mytakeonit to “buy all the cheap shres you can”. I consider $7 cheap too although I haven’t added since the $4s earlier this year. MannKind has been taking care of business and MNKD is finally starting to act like the stock of a company with well-managed fundamentals and prospects in the pipeline. 2025 should be a very interesting year and 2026 even better. |
|
|
|
Post by longliner on Nov 11, 2024 23:58:13 GMT -5
Focus folks. MNKD is up big this year and so far seems to have legs. MNKD-201 may be a significant piece of that with investors taking advice from mytakeonit to “buy all the cheap shres you can”. I consider $7 cheap too although I haven’t added since the $4s earlier this year. MannKind has been taking care of business and MNKD is finally starting to act like the stock of a company with well-managed fundamentals and prospects in the pipeline. 2025 should be a very interesting year and 2026 even better. PRC, to be fair, I've not lost any focus. I own a substantial number of MNKD shares. I am perplexed at Pro-boards continued acceptance of MNKD negative influence here. |
|
|
|
Post by prcgorman2 on Nov 12, 2024 0:04:30 GMT -5
Understood. I try to be respectful of divergent views. I may not share them and will offer reasons why, but I am tired of discord. Been too much. As for negativity, I’ve decided to put it down as some folks are more difficult to please than others.  |
|
As discussed before, you and I have very different incentives. I own shares.